A citation-based method for searching scientific literature

J Kevin Baird. Clin Microbiol Rev 2019
Times Cited: 46







List of co-cited articles
381 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria.
Jason W Bennett, Brandon S Pybus, Anjali Yadava, Donna Tosh, Jason C Sousa, William F McCarthy, Gregory Deye, Victor Melendez, Christian F Ockenhouse. N Engl J Med 2013
186
36

Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria.
J Kevin Baird, Melva Louisa, Rintis Noviyanti, Lenny Ekawati, Iqbal Elyazar, Decy Subekti, Krisin Chand, Anggi Gayatri, Instiaty, Saraswati Soebianto,[...]. JAMA Netw Open 2018
54
36

Antimalarial activity of primaquine operates via a two-step biochemical relay.
Grazia Camarda, Piyaporn Jirawatcharadech, Richard S Priestley, Ahmed Saif, Sandra March, Michael H L Wong, Suet Leung, Alex B Miller, David A Baker, Pietro Alano,[...]. Nat Commun 2019
54
26


Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
Marcus V G Lacerda, Alejandro Llanos-Cuentas, Srivicha Krudsood, Chanthap Lon, David L Saunders, Rezika Mohammed, Daniel Yilma, Dhelio Batista Pereira, Fe E J Espino, Reginaldo Z Mia,[...]. N Engl J Med 2019
114
23

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
Alejandro Llanos-Cuentas, Marcus V G Lacerda, Tran T Hien, Iván D Vélez, Chayadol Namaik-Larp, Cindy S Chu, Maria F Villegas, Fernando Val, Wuelton M Monteiro, Marcelo A M Brito,[...]. N Engl J Med 2019
105
23

The metabolism of primaquine to its active metabolite is dependent on CYP 2D6.
Brandon S Pybus, Sean R Marcsisin, Xiannu Jin, Gregory Deye, Jason C Sousa, Qigui Li, Diana Caridha, Qiang Zeng, Gregory A Reichard, Christian Ockenhouse,[...]. Malar J 2013
123
21

Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.
Ronnatrai Rueangweerayut, Germana Bancone, Emma J Harrell, Andrew P Beelen, Supornchai Kongpatanakul, Jörg J Möhrle, Vicki Rousell, Khadeeja Mohamed, Ammar Qureshi, Sushma Narayan,[...]. Am J Trop Med Hyg 2017
66
21

Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling study.
Katherine E Battle, Tim C D Lucas, Michele Nguyen, Rosalind E Howes, Anita K Nandi, Katherine A Twohig, Daniel A Pfeffer, Ewan Cameron, Puja C Rao, Daniel Casey,[...]. Lancet 2019
150
21

Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.
Pamela L St Jean, Zhengyu Xue, Nick Carter, Gavin C K W Koh, Stephan Duparc, Maxine Taylor, Claire Beaumont, Alejandro Llanos-Cuentas, Ronnatrai Rueangweerayut, Srivicha Krudsood,[...]. Malar J 2016
56
19

Primaquine radical cure of Plasmodium vivax: a critical review of the literature.
George K John, Nicholas M Douglas, Lorenz von Seidlein, Francois Nosten, J Kevin Baird, Nicholas J White, Ric N Price. Malar J 2012
135
19

CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine.
Brandon S Pybus, Jason C Sousa, Xiannu Jin, James A Ferguson, Robert E Christian, Rebecca Barnhart, Chau Vuong, Richard J Sciotti, Gregory A Reichard, Michael P Kozar,[...]. Malar J 2012
80
19

Differential CYP 2D6 metabolism alters primaquine pharmacokinetics.
Brittney M J Potter, Lisa H Xie, Chau Vuong, Jing Zhang, Ping Zhang, Dehui Duan, Thu-Lan T Luong, H M T Bandara Herath, N P Dhammika Nanayakkara, Babu L Tekwani,[...]. Antimicrob Agents Chemother 2015
56
17

Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
Alejandro Llanos-Cuentas, Marcus V Lacerda, Ronnatrai Rueangweerayut, Srivicha Krudsood, Sandeep K Gupta, Sanjay K Kochar, Preetam Arthur, Nuttagarn Chuenchom, Jörg J Möhrle, Stephan Duparc,[...]. Lancet 2014
181
17

Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art.
Sean R Marcsisin, Gregory Reichard, Brandon S Pybus. Pharmacol Ther 2016
65
17

Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population.
Michele D Spring, Jason C Sousa, Qigui Li, Christian A Darko, Meshell N Morrison, Sean R Marcsisin, Kristin T Mills, Brittney M Potter, Kristopher M Paolino, Patrick S Twomey,[...]. J Infect Dis 2019
17
47

Geographical variation in Plasmodium vivax relapse.
Katherine E Battle, Markku S Karhunen, Samir Bhatt, Peter W Gething, Rosalind E Howes, Nick Golding, Thomas P Van Boeckel, Jane P Messina, G Dennis Shanks, David L Smith,[...]. Malar J 2014
168
17

Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.
Mallika Imwong, Georges Snounou, Sasithon Pukrittayakamee, Naowarat Tanomsing, Jung Ryong Kim, Amitab Nandy, Jean-Paul Guthmann, Francois Nosten, Jane Carlton, Sornchai Looareesuwan,[...]. J Infect Dis 2007
229
17

Estimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis.
Robert J Commons, Julie A Simpson, James Watson, Nicholas J White, Ric N Price. Am J Trop Med Hyg 2020
37
21

A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.
Alison Roth, Steven P Maher, Amy J Conway, Ratawan Ubalee, Victor Chaumeau, Chiara Andolina, Stephen A Kaba, Amélie Vantaux, Malina A Bakowski, Richard Thomson-Luque,[...]. Nat Commun 2018
81
15

Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis.
Ric N Price, Lorenz von Seidlein, Neena Valecha, Francois Nosten, J Kevin Baird, Nicholas J White. Lancet Infect Dis 2014
229
15

The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.
A Gaedigk, S D Simon, R E Pearce, L D Bradford, M J Kennedy, J S Leeder. Clin Pharmacol Ther 2008
523
15

The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.
Robert J Commons, Julie A Simpson, Kamala Thriemer, Georgina S Humphreys, Tesfay Abreha, Sisay G Alemu, Arletta Añez, Nicholas M Anstey, Ghulam R Awab, J Kevin Baird,[...]. Lancet Infect Dis 2018
61
15


Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds.
Sean R Marcsisin, Jason C Sousa, Gregory A Reichard, Diana Caridha, Qiang Zeng, Norma Roncal, Ronan McNulty, Julio Careagabarja, Richard J Sciotti, Jason W Bennett,[...]. Malar J 2014
62
13

Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta).
Geoffrey S Dow, Montip Gettayacamin, Pranee Hansukjariya, Rawiwan Imerbsin, Srawuth Komcharoen, Jetsumon Sattabongkot, Dennis Kyle, Wilbur Milhous, Simon Cozens, David Kenworthy,[...]. Malar J 2011
49
13

Prediction of CYP2D6 phenotype from genotype across world populations.
Andrea Gaedigk, Katrin Sangkuhl, Michelle Whirl-Carrillo, Teri Klein, J Steven Leeder. Genet Med 2017
261
13

Effects of MAO-A and CYP450 on primaquine metabolism in healthy volunteers.
Norliza Mat Ariffin, Farida Islahudin, Endang Kumolosasi, Mohd Makmor-Bakry. Parasitol Res 2019
9
66

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
Walter R J Taylor, Kamala Thriemer, Lorenz von Seidlein, Prayoon Yuentrakul, Thanawat Assawariyathipat, Ashenafi Assefa, Sarah Auburn, Krisin Chand, Nguyen Hoang Chau, Phaik Yeong Cheah,[...]. Lancet 2019
64
13

Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
Cindy S Chu, Aung Pyae Phyo, Claudia Turner, Htun Htun Win, Naw Pet Poe, Widi Yotyingaphiram, Suradet Thinraow, Pornpimon Wilairisak, Rattanaporn Raksapraidee, Verena I Carrara,[...]. Clin Infect Dis 2019
31
19

Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model.
Leanne J Robinson, Rahel Wampfler, Inoni Betuela, Stephan Karl, Michael T White, Connie S N Li Wai Suen, Natalie E Hofmann, Benson Kinboro, Andreea Waltmann, Jessica Brewster,[...]. PLoS Med 2015
148
13

New developments in anti-malarial target candidate and product profiles.
Jeremy N Burrows, Stephan Duparc, Winston E Gutteridge, Rob Hooft van Huijsduijnen, Wiweka Kaszubska, Fiona Macintyre, Sébastien Mazzuri, Jörg J Möhrle, Timothy N C Wells. Malar J 2017
245
13

In Vitro Culture, Drug Sensitivity, and Transcriptome of Plasmodium Vivax Hypnozoites.
Nil Gural, Liliana Mancio-Silva, Alex B Miller, Ani Galstian, Vincent L Butty, Stuart S Levine, Rapatbhorn Patrapuvich, Salil P Desai, Sebastian A Mikolajczak, Stefan H I Kappe,[...]. Cell Host Microbe 2018
76
13

Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry.
Bharathi Avula, Babu L Tekwani, Narayan D Chaurasiya, Pius Fasinu, N P Dhammika Nanayakkara, H M T Bhandara Herath, Yan-Hong Wang, Ji-Yeong Bae, Shabana I Khan, Mahmoud A Elsohly,[...]. Malar J 2018
17
35

Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine.
A S ALVING, J ARNOLD, R S HOCKWALD, C B CLAYMAN, R J DERN, E BEUTLER, C L FLANAGAN. J Lab Clin Med 1955
80
13

CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study.
Larissa W Brasil, Fernanda Rodrigues-Soares, Ana B Santoro, Anne C G Almeida, Andrea Kühn, Rajendranath Ramasawmy, Marcus V G Lacerda, Wuelton M Monteiro, Guilherme Suarez-Kurtz. Malar J 2018
33
18

Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.
Sebastian A Mikolajczak, Ashley M Vaughan, Niwat Kangwanrangsan, Wanlapa Roobsoong, Matthew Fishbaugher, Narathatai Yimamnuaychok, Nastaran Rezakhani, Viswanathan Lakshmanan, Naresh Singh, Alexis Kaushansky,[...]. Cell Host Microbe 2015
130
13

PharmVar GeneFocus: CYP2D6.
Charity Nofziger, Amy J Turner, Katrin Sangkuhl, Michelle Whirl-Carrillo, José A G Agúndez, John L Black, Henry M Dunnenberger, Gualberto Ruano, Martin A Kennedy, Michael S Phillips,[...]. Clin Pharmacol Ther 2020
86
13

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.
Nicholas M Douglas, Jeanne Rini Poespoprodjo, Dewi Patriani, Michael J Malloy, Enny Kenangalem, Paulus Sugiarto, Julie A Simpson, Yati Soenarto, Nicholas M Anstey, Ric N Price. PLoS Med 2017
51
10


G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
Rosalind E Howes, Frédéric B Piel, Anand P Patil, Oscar A Nyangiri, Peter W Gething, Mewahyu Dewi, Mariana M Hogg, Katherine E Battle, Carmencita D Padilla, J Kevin Baird,[...]. PLoS Med 2012
298
10

Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei.
Erin E Milner, Jonathan Berman, Diana Caridha, Samuel P Dickson, Mark Hickman, Patricia J Lee, Sean R Marcsisin, Lisa T Read, Norma Roncal, Brian A Vesely,[...]. Malar J 2016
16
31

Age, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children.
Bronner P Gonçalves, Helmi Pett, Alfred B Tiono, Daryl Murry, Sodiomon B Sirima, Mikko Niemi, Teun Bousema, Chris Drakeley, Rob Ter Heine. Antimicrob Agents Chemother 2017
24
20


Differential cytochrome P450 2D metabolism alters tafenoquine pharmacokinetics.
Chau Vuong, Lisa H Xie, Brittney M J Potter, Jing Zhang, Ping Zhang, Dehui Duan, Christina K Nolan, Richard J Sciotti, Victor E Zottig, N P Dhammika Nanayakkara,[...]. Antimicrob Agents Chemother 2015
27
18

Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo.
Adeshina I Adekunle, Mykola Pinkevych, Rose McGready, Christine Luxemburger, Lisa J White, François Nosten, Deborah Cromer, Miles P Davenport. PLoS Negl Trop Dis 2015
57
10

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.
Kelly E Caudle, Katrin Sangkuhl, Michelle Whirl-Carrillo, Jesse J Swen, Cyrine E Haidar, Teri E Klein, Roseann S Gammal, Mary V Relling, Stuart A Scott, Daniel L Hertz,[...]. Clin Transl Sci 2020
191
10

Novel Insights into Plasmodium vivax Therapeutic Failure: CYP2D6 Activity and Time of Exposure to Malaria Modulate the Risk of Recurrence.
Ana Carolina Rios Silvino, Flora Satiko Kano, Marcelo Azevedo Costa, Cor Jesus Fernandes Fontes, Irene Silva Soares, Cristiana Ferreira Alves de Brito, Luzia Helena Carvalho, Tais Nobrega Sousa. Antimicrob Agents Chemother 2020
14
35

The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea.
R Joan H Ingram, Chelzie Crenna-Darusallam, Saraswati Soebianto, Rintis Noviyanti, J Kevin Baird. Malar J 2014
43
11

Relapse.
Nicholas J White, Mallika Imwong. Adv Parasitol 2012
104
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.